Description     Claims     Drawing  

WO2011148041A   [0015]  [0029] 
US2015026457W   [0029] 
US1547187W   [0034] 
US20130058962A   [0103] 
US4537776A   [0105] 
US62061507B   [0186] 
US62126556B   [0186] 
US62205443A   [0186] 

Antimicrobial Agents and Chemotherapy   [0007] 
Gut Microbes   [0013]  [0115]  [0174]  [0177] 
PLoS ONE   [0013]  [0115]  [0174]  [0177] 
Am. J. Gastroenter.   [0013] 
JBC   [0030] 
A standard numbering scheme for the Class A β-lactamases   [0033] 
Pharmacopeia 23NF/28USP   [0053] 
Antimicrob. Agents Chemother   [0102] 
Philos Trans R Soc Lond B Biol Sci.   [0102] 
Biochem J.   [0102] 
Intnat'l J Inf Dis   [0103] 
N Engl J Med.   [0103] 
PLoS ONE   [0169] 
Science   [0169] 
BMC Bioinformatics   [0171] 
PNAS   [0172] 
Am. J. Gastroenter   [0174] 
Am. J. Gastroent.   [0177] 
Int. J. Antimicrobial Agents   [0178] 
Microbial community profiling of human saliva using shotgun metagenomics sequencing   [0185] 
Longitudinal analysis of microbial interaction between humans and the indoor environment   [0185] 
A flexible R package for nonnegative matrix factorization   [0185] 
Diagnosis of multiple cancer types by shrunken centroids of gene expression   [0185] 
Methanogens in human health and disease   [0185] 
Pharmacodynamics of ceftriaxone and cefixime against community-acquired respiratory tract pathogens   [0185] 
Methanogens in human health and disease   [0185] 
Alteration of the fecal microbiota and serum metabolite profiles in dogs with idopathic inflammatory bowel disease   [0185] 
Comparison of microbiologics, histological, and immunomodulatory parameters in respoonse to treatment with either combination therapy with prednisone and metronidazole or probiotc VSL#3 strains in dogs with idopathic inflammatory bowel disese   [0185]